Urol. praxi, 2014; 15(1): 12-17
Metaphylaxis of urolithiasis in 2013
- Urologická klinika FN a LF UP, Olomouc
The right differentiation of patients based on the degree of their disorders’ risk is an essential precondition for the appropriate use of
secondary prevention. In fact, 75 per cent of patients’ disorders classify as low risk. Such cases can be treated according to the principles
of general metaphylaxis. Only 25 per cent of patients face a high risk of further attacks. Consequently, it is imperative to identify
these cases in time and perform additional metabolic tests. Having correctly identified the individual biochemical risk in these patients,
a specific metaphylaxis approach using suitable drugs must be taken.
Keywords: urolithiasis, risk factors, metabolic tests, metaphylaxis
Published: February 1, 2014 Show citation
References
- Zvara V, Revúsová V. Močové konkrementy. Veda 1988: 268 s.
- Křížek V, Sadílek L. Urolitiáza, etiopatogeneze, konzervativní terapie a prevence. Praha: Avicenum 1990.
- Stejskal D. Metabolická problematika v léčbě urolitiázy. Urol. Praxi, 2009; 10(2): 72-78.
- Arbeitskreis, ,Harnsteine" der Akademie der Deutschen Urologen. S2 Leitlinien zu Diagnostik, Therapie und Metaphylaxe der Urolithiasis. Urologe, 2009; 48 (9): 1084-1093.
Go to original source... 
Go to PubMed... - Staub M. Metaphylaxe von Harnsteinerkrankungen. Urologe, 2011; 50(10): 1323-1334. Go to original source... Go to PubMed...
- Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C. EAU Guidelines on urolithiasis 2013. Dostupný z WWW: http://www.Uroweb.org.
- Rajmon P, Mucha Z. Kalciumoxalátová litiáza - zásadní význam sekundární prevence. Urol. Praxi, 2008; 9(5): 216-222.
- Kočvara R, Ptáček V, Ťuíková J. Metafylaxe urolitiázy, způsob a výsledky. Čas. Lék. Čes, 1989; 128: 266-269.
- Ganter K, Winter P, Brockhaus S, Hesse A. Alkalisierung des Harns zur Metaphylaxe bei Kalziumoxalatsteinen K- Zitrat v.s. Na-K- Zitrat. Urologe B, 1996; 36(6): 461-465. Go to original source...
- Rinnab L, Hautmann RE, Straub M. Alkalitzitrate in der Urologie. Urologe A, 2004; 43(4): 429-439. Go to original source... Go to PubMed...
- Stejskal D. Etiopatogeneze a metafylaxe metabolických poruch a rizik urolitiázy. Interní Med., 2003; 1: 8-14.
- Grasses F, Connte A. Urolithiasis, inhibitors and promoters. Urological Research, 1992; 20(1): 86-88. Go to original source... Go to PubMed...
- Straub M, Hautmann RE, Hesse A, Rinnab L. Kalciumoxalatharnsteine und Hyperoxalurie. Urologe A, 2005; 44(11): 1315-1323. Go to original source... Go to PubMed...
- Wilbert DM, Wechsel HW, Lahme S. Diagnostik und Therapie der Urolithiasis-Tübinger Koncept. Urologe B, 1998; 38(6): 509-521. Go to original source...
- Meissner A, Mamoulakis C, Laube N. Harnweginfektionen und Urolithiasis. Urologe, 2010; 49(5): 623-628. Go to original source... Go to PubMed...
- Král R, Krhut J. Cystinová urolitiáza - komplexní řešení. Urol. Praxi, 2010; 11(3): 152-153.